Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer

about

Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer

Item

http://www.wikidata.org/entity/Q38905885

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Trends in phase III randomized ...... ced non-small-cell lung cancer

@en

type

Item

label

Trends in phase III randomized ...... ced non-small-cell lung cancer

@en

prefLabel

Trends in phase III randomized ...... ced non-small-cell lung cancer

@en

P1476

Trends in phase III randomized ...... ced non-small-cell lung cancer

@en

P2093

Cristina Fernández-López

http://www.w3.org/2001/XMLSchema#string

Isabel Linares

http://www.w3.org/2001/XMLSchema#string

José Cabeza-Barrera

http://www.w3.org/2001/XMLSchema#string

José Expósito-Hernández

http://www.w3.org/2001/XMLSchema#string

Juan Pedro Arrebola-Moreno

http://www.w3.org/2001/XMLSchema#string

Manuela Expósito-Ruíz

http://www.w3.org/2001/XMLSchema#string

Miguel Ángel Calleja-Hernández

http://www.w3.org/2001/XMLSchema#string

Rosa Guerrero-Tejada

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Cancer statistics, 2014

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis.

Quality-of-life assessment in oncology. Achievements and challenges.

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapy

Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time.

New chemotherapy treatments in advanced cancer patients: an easily applicable evaluation of clinical efficacy and cost-effectiveness.

P304

2190-2197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1002/CAM4.782

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27449070

http://www.w3.org/2001/XMLSchema#string

P921

non-small-cell lung carcinoma

phase III clinical trial

lung cancer

P932

5055155

http://www.w3.org/2001/XMLSchema#string